Skip to Main Content
1-866-831-5700
Trending Searches
Back to Navigation

Hazelden Betty Ford: Treatment Results and Patient Outcomes

Today, as the world faces an addiction and mental health crisis of historic proportion, Hazelden Betty Ford’s breakthrough approach is needed more than ever—advancing treatment that works and recovery that lasts.

Percentage of Hazelden Betty Ford Foundation patients reporting Good or Better quality of life by year 2021 86% 2022 87% 2023 86%. This is 17% higher than adults surveyed nationally.

 

 

The most common mental health diagnoses among Hazelden Betty Ford Foundation substance use disorder patients are anxiety (52.3%), depression (40.3%) and trauma and stress-related disorders (37.7%). Anxiety symptoms decrease by 41% and depression symptoms decrease by 46% in residential substance use disorder patients. Sums are greater than the overall sample size as patients could have multiple mental health diagnoses.

 

 

Cravings decrease over time. The percentage of patients who report having no craving or mild cravings over time is 1 month 77%, 3 months 75%, 6 months 77%, 9 month 79% and 12 month 81%.
Even with advances in treatment, return to use occurs. In 12-month follow-up, 72% of Hazelden Betty Ford Foundation patients report being sober from alcohol and 87% report being sober from drug use. On average, 50% to 60% of patients begin re-using substances within 6 months following the end of treatment.

 

 

79% of patients had more than one diagnosis. The average number of diagnoses per patient is 3.67.

 

 

Anti-craving medication rates by year are 2020 39%, 2021 46%, 2022 50%, and 2023 43%. Anti-craving medication adherence rates by year are 2020 76%, 2021 81%, 2022 79% and 2023 81%. These adherence rates are much higher than the average adherence rate for medication, which is around 50%.

Helping People Outlive the Disease of Addiction

We are ready to help you outlive this chronic disease. Our ongoing patient monitoring shows that twice (2x) as many of our patients report continuous sobriety during the year after treatment than industry rates found in addiction treatment research.

The patient data supports the effectiveness of our clinical model of care, measured by the length of sobriety, management of cravings and other indicators well-being—revealing the benefits of treatment.

With the right care, support and time, recovery from substance use disorders isn’t just the norm. Recovery is the catalyst for an all-around better quality of life.

The Research Is In

The Hazelden Betty Ford Foundation is redefining addiction treatment that helps patients outlive their disease. We stay at the forefront of addiction treatment by doing our own groundbreaking research. The latest patient outcomes data, monitored and analyzed by Hazelden Betty Ford’s Butler Center for Research, demonstrate the sweeping impact of our treatment in real-life terms for families. This outcomes data analysis marks a first in our industry—a multiyear, comprehensive survey on patients during and after treatment with Hazelden Betty Ford.

About the Butler Center for Research

Hazelden Betty Ford has documented the effectiveness of its treatment programs from the very start, with the first patient follow-up report issued in 1950. Led by PhD-level clinicianresearchers, the Butler Center for Research maintains the integrity of our outcomes by operating separately from clinical care and using evidence-based research methods backed by third-party National Institutes of Health advisors. The Butler Center for Research continues our rigorous search for increasingly effective treatment solutions.

1-866-831-5700